Apolipoprotein-AII (APOAII) isoforms (especially APOAII-2) have been suggested to be potential biomarker surrogates for pancreatic cancer and their clinical usefulness has been evaluated via multi-institutional validation [17]. The gene discussed is APOA2; the disease is familial pancreatic carcinoma.